Description
Composition:
Each vial contains:
Dacarbazine IP 200 mg
PACKING: 1 Vial Injection
INDICATIONS: Dacarbazine Injection IP 200 mg is indicated in
the treatment of metastatic malignant melanoma. In addition,
Dacarbazine Injection IP 200 mg is also indicated for Hodgkin’s
disease as a secondary – line – therapy when used in
combination with other effective agents.
Reviews
There are no reviews yet.